Zoll Medical Corporation, which received FDA clearance a few years ago for both home and hospital versions of its wearable defibrillator LifeVest, is now dealing with a range of lawsuits and FDA ...
Good news for resuscitation devices maker ZOLL Medical (NasdaqGS:ZOLL - News) as the Centers for Medicare and Medicaid Services (“CMS”) has reaffirmed the existing coverage policy for the company’s ...
ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, ...
81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...
European Heart Journal publishes SCD-PROTECT study, addressing evidence gap in early SCD risk in the context of four-pillar GDMT for both NICM and MI/CAD patients ZOLL®, an Asahi Kasei company that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback